The Effect of an Aqueous Extract of Teucrium polium on Glutathione Homeostasis In Vitro: A Possible Mechanism of Its Hepatoprotectant Action by Shtukmaster, Stella et al.
Hindawi Publishing Corporation
Advances in Pharmacological Sciences
Volume 2010, Article ID 938324, 7 pages
doi:10.1155/2010/938324
Research Article
TheEffectof an AqueousExtract of Teucriumpolium on
Glutathione Homeostasis In Vitro: A Possible Mechanism of
Its Hepatoprotectant Action
Stella Shtukmaster,PredragLjubuncic,and AriehBomzon
Department of Pharmacology, Bruce and Ruth Rappaport Faculty of Medicine, Technion-Israel Institute of Technology,
P.O. Box 9649, Haifa 31096, Israel
Correspondence should be addressed to Arieh Bomzon, arieh.bomzon@gmail.com
Received 8 June 2009; Revised 25 November 2009; Accepted 15 January 2010
Academic Editor: Chun Guang Li
Copyright © 2010 Stella Shtukmaster et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Background. Teucrium polium is used in Arab traditional medicine to treat liver diseases. Glutathione is an important intracellular
antioxidant, and intrahepatic glutathione levels are depleted in liver diseases. Hypothesis and Aim. This investigation tested the
hypothesis that aqueous extracts of T. polium maintains intracellular glutathione levels by augmenting glutathione peroxidase
and glutathione reductase activity in cultured hepatocytes. Methods. The eﬀects of increasing concentrations (0.01–1mg/mL) of
aqueous extract of T. polium were assessed in cultured HepG2 cells following 24 hours incubation on (1) cellular integrity using
(a) the Trypan blue exclusion assay, (b) the [di-methylthiazol-2yl]-2,5-diphenyl-tetrazoliumbromide (MTT) assay, and (c) the
lactatedehydrogenase(LDH)assay;(2)glutathioneredoxstate;and(3)glutathioneperoxidaseandglutathionereductaseactivities
using a repeated measures experimental design. Results. At concentrations of 0.375mg/mL and 0.5mg/mL, the extract increased
the intracellular levels of total and reduced glutathione and had no eﬀect on the intracellular amounts of oxidized glutathione.
The extract had no eﬀect on glutathione peroxidase and glutathione reductase activities. Conclusion. These data indicate that
the mechanism of the hepatoprotective action of aqueous extracts of T. polium may be, in part, due to augmenting intracellular
glutathione levels.
1.Introduction
In traditional Arab medicine, an extract of Teucrium
polium (Polygermander), a member of Lamiaceae family and
widely distributed in the hills and deserts of Mediterranean
countries, is used to treat liver disease, hypertension, and
diabetes [1]. The extract is also used as an antiemetic,
an antispasmodic, an antiinﬂammatory, an antipyretic, an
analgesic, and an anti-carminative, and in the treatment of
hyperlipidemia and peptic ulcers [2].
The therapeutic beneﬁts of T. polium extracts are usually
attributed to their ability to suppress oxidative processes.
For example, Suboh and colleagues [3] showed that an
alcoholic extract of T. polium could suppress hydrogen
peroxide-induced lipid peroxidation in red blood cells in a
concentration-dependent manner. Previously, we reported
thatanaqueousextractofT. polium suppressediron(Fe2+)—
induced lipid peroxidation in rat liver homogenates at
concentrations that were not toxic to cultured hepatocytes
[4]. We also reported that an aqueous extract of the plant
could scavenge the superoxide anion and hydroxyl radical in
a concentration-dependent manner and could inhibit other
oxidative processes in vitro, such as the oxidation of β-
carotene and plasma, as well as chelating iron [5].
There is evidence that the liver is oxidatively stressed
in hepatic disease due to ongoing oxidative processes and
depletion of intrahepatic glutathione levels [6, 7]. Based on
the fact that extracts of T. polium are still widely used to
treat liver disease in traditional medicine, it is reasonable
to assume that the possible mechanisms of the extract’s
therapeutic actions are due to the extract’s ability to suppress
oxidative processes and maintain endogenous antioxidant2 Advances in Pharmacological Sciences
levels. However, there are no laboratory data on the extract’s
eﬀects on endogenous antioxidants, such as glutathione.
Therefore, we designed a study to assess the eﬀects of an
aqueous extract of T. polium on intracellular glutathione
homeostasis. In addition, we also assessed the eﬀects of
increasing concentrations of an aqueous extract on cellular
viabilityandintegrityofculturedhepatocytes,andtheresults
are presented in the current communication.
2.MaterialsandMethods
2.1. Plant Material and Extract Preparation. Leaves and the
stems of T. polium were collected during spring (May-June)
from the hills of the Galilee region of Israel. After collection,
the plant parts were dried for 7–10 days in the shade at room
temperature. They were then ground and the powder was
s t o r e di nc l o t hb a g sa t5 ◦C until the aqueous extract was
prepared. For this purpose, the dried plant material (25g)
was stirred in 250mL of distilled water for 15 min at 95◦C,
followedbyrapidﬁltrationﬁrstbyacrudecelluloseﬁlterand
then using Whatman #1 ﬁlter paper. The average w/w yield
was 11.5%. The resulting solution was freeze-dried and the
powder was stored at −18
◦C in a desiccant until required.
2.2. Chemical and Reagents. All culture media and reagents
for the assays that involved cultured hepatocytes were
purchased from Biological Industries Ltd., Beit Haemek,
Israel. All other chemicals and reagents were of the highest
purity grade and purchased from the Sigma Chemical Co.,
St. Louis, MO, USA.
2.3. Cell Culture. The eﬀects of an aqueous extract of T.
polium on cellular integrity, glutathione redox state, and
the activities of GPx and GR were assessed in cultured
HepG2 cells. HepG2 cells are derived from human hepato-
blastoma and retain many of the diﬀerentiated features of
mature hepatocytes [8]. The cells were grown in Roswell
Park Memorial Institute medium (RPMI 1640) that con-
tained glucose (2g/L) and supplemented with 10% fetal
calf serum, 10000U/mL penicillin, 10mg/mL streptomycin,
1% glutamine, 1% Hepes buﬀer solution, pH 7.4, and
maintained in a humidiﬁed atmosphere of 95% O2 :5%
CO2 at 37◦C. At 80% conﬂuence, cells were trypsinized,
centrifuged (1700rpm for 5 minutes at room temperature),
resuspended in fresh medium, and plated in microtiter wells
(2 ×104 cells/well) or in six-well dishes (106 cells/well). After
attachment, they were incubated in serum-free medium to
w h i c h0 . 0 1 – 1 m g / m Le x t r a c tw a sa d d e da n dk e p tf o r2 4
hours at 37◦C.
2.4. Assays of Cellular Integrity. Three diﬀerent assays
were used to assess the eﬀect of the extract on cellular
integrity: (a) the Trypan blue exclusion test to determine
cell viability, (b) the [di-methylthiazol-2yl]-2,5-diphenyl-
tetrazoliumbromide (MTT) assay to monitor mitochondrial
respiration; (c) the lactate dehydrogenase (LDH) assay to
assess plasmalemma integrity.
2.4.1. Trypan Blue Exclusion Assay. The Trypan blue exclu-
sion assay is widely used to determine cellular integrity
[9, 10]. HepG2 cells (2 × 106 cells/well) were incubated with
0.01 – 1 mg/mL plant extract for 24 hours at 37◦C. The
cells were then exposed to the dye and the number of cells
that took up the dye was counted in a hemocytometer. The
proportion of dye-containing cells to cells that did not take
up the dye was then calculated. The experiment was repeated
between 7–10 times.
2.4.2. MTT Assay. The MTT assay is a test of metabolic
competenceandassessesmitochondrial performance[9,10].
It is a colometric assay that relies on the conversion of
yellow tetrazolium bromide (MTT) to the purple formazan
derivative by mitochondrial succinate dehydrogenase in
viable cells[11]. Brieﬂy, HepG2 cells (2×104 cells/well) were
ﬁrst incubated with 0.01–1mg/mL plant extract for 24 hours
at37◦C.Thecellswerethenincubatedinserum-freemedium
to which MTT (0.5mg/mL, 10μL) was added. Following
3.5 hours incubation, 100μL acidic isopropanol (0.04–0.1N
HCl in absolute isopropanol) were added to dissolve the
formazan crystals and the absorbance was determined in an
ELISA reader at 570/650nm. The number of metabolically
competent cells was determined as the ratio (expressed as a
percentage) of absorbance of treated cells to untreated cells
that served as control. The experiment was repeated nine
times.
2.4.3. LDH Assay. The presence of the cytosolic enzyme,
LDH, in the cell culture medium is indicative of cell
membrane damage [9, 10]. Brieﬂy, HepG2 cells (2 ×
104 cells/well) were ﬁrst incubated with 0.1–1mg/mL plant
extracts for 24 hours at 37◦C. Upon completion of the
incubation, 50μL of the upper medium were collected from
each well. The untreated cells were then lysed with a cell
lysis solution for 40 minutes at room temperature and the
lysate collected. LDH activity was measured using CytoTox
96 Nonradioactive Cytotoxicity Assay Kit (Promega, WI,
USA), in accordance with manufacturer’s instructions. The
percent of LDH released from the cells was determined using
the formula: (absorbance of supernatant)/(absorbance of
supernatant + absorbance of lysate) × 100. The experiment
was repeated seven times.
2.5. Determination of Total Intracellular Amount of Glu-
tathione. HepG2 cells were seeded and grown in cell ﬂasks
under the identical conditions which have already been
described. At 80% conﬂuence, cells were trypsinized, cen-
trifuged (1700rpm for 5 minutes at room temperature),
resuspended in fresh medium, and plated in six-well dishes
(106 cells/well). After attachment, the medium was replaced
and cells were incubated in fresh serum-free medium
containing the extract for 24 hours at 37◦C. The nontreated
cells served as the control. At the end of incubation period,
the cells were washed three times with Dulbecco’s phosphate
buﬀered saline (PBS). After washing, the cells were scraped
into 1mL PBS. To extract cellular GSH, the cells were
then dispersed using a sonicator by two 20 sec bursts. AnAdvances in Pharmacological Sciences 3
aliquot of sonicate was taken for protein determination [12].
The remainder of sonicate was immediately acidiﬁed with
5% sulfosalicylic acid (2 : 1 v/v) to prevent spontaneous
oxidation of GSH. After standing for 10m on ice, the
sonicate was centrifuged at 10000rpm for 10 min at 4◦Ct o
remove the denaturated proteins. The resultant supernatants
were transferred into 1.7mL plastic tubes and the acidiﬁed
samples were frozen at −70◦C until use that was always less
than one week.
GSH levels were determined using the DTNB-GSSG
reductase recycling assay [13] with minor modiﬁcations.
Before measurement of GSH, the sample was thawed and
back titrated to pH 7.0 with 0.2N NaOH. Total GSH content
(the sum of the reduced and oxidized forms of glutathione)
and the oxidized form (GSSG) were measured separately.
The GSH assay was performed in cuvette that contained
0.01M sodium phosphate buﬀer (pH 7.5), 5mM EDTA,
10mM 5,5 -dithio-bio-2-nitrobenzoic acid (DTNB), 2mM
nicotinamide adenine dinucleotide phosphate (NADPH),
10U/mL glutathione reductase, and approximately 100μg
cell protein in a ﬁnal volume of 1mL. The reaction kinetics
were followed spectrophometrically at 412nm for 5 minutes
by monitoring the increase in absorbance.
For determination of GSSG content, the identical DTNB
recycling assay was performed after alkylation of the SH
groups of reduced glutathione by 10mM N-ethylmaleimide
(NEM) in order to remove reduced glutathione from
the reaction. To avoid the adverse eﬀects of excess N-
ethylmaleimide in the assay used to determine GSSG levels,
excess NEM was removed by separation on a Sep-Pak (C18)
column (Sigma Chemical Corp., MI, USA). The increments
in absorbance at 412nm were converted to GSH and
GSSG concentrations using a standard curve (0–2.5nmol
GSSG). The results were expressed in nmol/mg protein. The
experiment was repeated eight times in which duplicate GSH
and GSSG determinations were done.
2.6. Determination of Glutathione Peroxidase (GPx) Activity.
HepG2 cells were seeded and grown in cell ﬂasks and then in
six-well dishes (106 cells/well) under the identical conditions
that have already been described. At the end of incubation
period HepG2 cells were washed and scraped into 1mL
PBS and then were sonicated in the same manner as were
prepared for glutathione determination. An aliquot (100μL)
of the sonicate was taken for protein determination [12].
The remainder of sonicate was then used to determine the
activities of the enzymes.
The enzyme, GPx, detoxiﬁes peroxides in the cell. Due
to the fact that peroxides can decompose to form highly
reactive radicals, GPx plays a vital role in protecting the
cell from free radical-induced damage, particularly lipid
peroxidation. The enzyme also catalyzes the reduction of
hydrogen peroxide and organic peroxides (R–O–O–H) to
water and corresponding stable alcohols (R–O–H), respec-
tively, using reduced glutathione as a source of reducing
equivalents. When oxidized glutathione is produced upon
reduction of organic peroxide by GPx, it is recycled to
its reduced state by GR with oxidation of NADPH to
NADP+. The process of NADPH oxidation is accompanied
by a decrease in absorbance at 340nm thereby providing
a spectrophotometric means for monitoring the activity
of GPx. GPx was assayed using t-butylhydroperoxide (t-
BOOH) as a substrate [14]. The assay was performed in
cuvette that contained 1M Buﬀer Tris-HCl + 5mM EDTA
(pH 8.0), 0.1M GSH, 2mM NADPH, 10U/mL glutathione
reductase, sample, and t-butylhydroperoxide diluted 1:1000
with distilled water in a ﬁnal volume of 1.0mL. The decrease
in absorbance, reﬂecting the oxidation of NADPH which
directly proportional to the GPx activity in the sample, was
followed at 340nm. Results were expressed as units of GPx
activity/mg cell protein. The experiment was repeated ten
times.
2.7. Determination of Glutathione Reductase (GR) Activity.
The enzyme, GR, catalyzes the reduction of GSSG to
GSH and is essential for the glutathione redox cycle in
order to maintain adequate levels of reduced cellular GSH.
During the reduction of GSSG by glutathione reductase,
one molecule of NADPH is consumed for each molecule of
GSSG reduced. Therefore, the reduction of GSSG by GR can
be determined by the measurement of the consumption of
NADPH. The activity of GR was assayed using the method
that was described by Carlberg and Mannervik [15]w i t h
minor modiﬁcations. The GR assay was performed in a
cuvette that contained 1M Tris-HCl buﬀer + 5mM EDTA
(pH 8.0), 0.033M GSSG, 2mM NADPH, and a sample
in a ﬁnal volume of 1.0mL. The decrease in absorbance,
which reﬂects the oxidation of NADPH during reduction
of GSSG by GR present in the sample, was monitored
spectrophotometrically at 340nm. Results were expressed as
units of GR activity/mg cell protein. The experiment was
repeated ten times.
2.8. Statistical Analysis of the Data. T h es a m p l es i z ef o re a c h
experiment was determined by power analysis arbitrarily set
a t8 0 %i no r d e rt od e t e c ta ne ﬀect at 5% probability using
Statemate version 1 (GraphPad Software, Inc., San Diego,
CA, USA). The eﬀect of the varying concentrations of the
extract was assessed on the various study parameters using
a repeated measures experimental design. The data of the
eﬀects of an aqueous extracts of T. polium on cell viability,
the glutathione redox state and, and the activities of GPx and
GR were analyzed by one-way analysis of variance (ANOVA)
with a Dunnett’s posttest. All data are expressed as mean ±
standard deviation.
3. Results
3.1. The Eﬀect of an Aqueous Extract of T. polium on the
Integrity of HepG2 Cells. First, we examined the eﬀect of
the increasing concentrations of extract of T. polium on
the viability of cultured HepG2 cells using the Trypan blue
exclusion test and found that the extract had no eﬀect on
cellular viability following 24 hours incubation with the
extract (data not shown).4 Advances in Pharmacological Sciences
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Figure 1: Eﬀect of increasing concentrations of an aqueous extract
of T. polium on mitochondrial respiration in HepG2 cultured cells
using the MTT assay. Data are presented as mean ± standard devi-
ation. Sample size (n) = 9. ∗p<0.01 represents the signiﬁcance of
the diﬀerence from the control. All data are depicted as a percentage
with respect to control (100% mitochondrial respiration).
We then used the MTT assay to assess the eﬀect of
the identical concentrations of the aqueous extract on
the mitochondrial respiration of cultured HepG2 cells. At
the lower concentrations, 0.05–0.25mg/mL, the aqueous
extract boosted mitochondrial respiration (p<0.01). At
the concentrations of 0.01mg/mL and 0.5mg/mL, the
extract had no eﬀect on mitochondrial respiration. At
higher concentrations 0.75–1mg/mL, the extract inhibited
mitochondrial respiration (p<0.01) (Figure 1).
The LDH assay was then used to determine the eﬀect of
the extract on the integrity of the plasmalemma of cultured
HepG2 cells. At the low concentrations, 0.01–0.25mg/mL,
the extract had no eﬀect on the LDH leakage following 24
hours incubation. At higher concentrations 0.5–1mg/mL,
the extract increased cellular LDH eﬄux (p<0.01)
(Figure 2).
Based on these ﬁndings, three concentrations of the
extract, namely, 0.25mg/mL, 0.375mg/mL, and 0.5mg/mL
of the extract, were then used to evaluate the eﬀect of the
extract on intracellular glutathione homeostasis.
3.2. The Eﬀect of an Aqueous Extract of T. polium on Total
Glutathione Levels in Cultured HepG2 Cells. Over the 0.375–
0.5mg/mL concentration range, the extract signiﬁcantly
increased (p<0.01) the intracellular levels of total
(Figure 3), reduced glutathione (Figure 4), and had no eﬀect
on the amount of GSSG (data not shown) in HepG2 cells.
The results of total and reduced glutathione are similar
because intracellular glutathione is found almost exclusively
in its reduced form.
Due to the fact that the aqueous extract increased
the reduced glutathione levels without aﬀecting oxidized
glutathione levels over the 0.375–0.5mg/mL concentration
range, the GSH/GSSG ratio increased.
3.3. The Eﬀect of an Aqueous Extract of T. polium on
the Activities of Glutathione Peroxidase and Glutathione
Concentration of T. polium extract (mg/mL)
Control
T. polium 0.01mg/mL
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Figure 2: Eﬀect of increasing concentrations of an aqueous extract
of T. polium on membrane integrity in HepG2 cultured cells using
the LDH assay. Data are presented as mean ± standard deviation.
Sample size (n) = 7. ∗p<0.01 represents the signiﬁcance of the
diﬀerence from the control. All data are presented as a percentage
of the total (100%).
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Figure 3: Eﬀect of a 24-hour exposure of an aqueous extract of T.
polium on total glutathione levels in HepG2 cultured cells. Data are
presented as mean ± standard deviation. Sample size (n) = 8. ∗p<
0.01 represents the signiﬁcance of the diﬀerence from the control.
Reductase. Over the 0.25–0.5mg/mL concentration range,
we found that the extract had no eﬀect on the activities of
GPx (Figure 5)a n dG R( Figure 6) after a 24-hour exposure.
4. Discussion
The aim of this work was to assess the eﬀects of an aqueous
extract of T. polium on the homeostasis of intracellular
glutathione. In this study, we found that an aqueous extract
of T. polium had no eﬀect on cellular integrity at low
(0.01–0.25mg/mL)concentrations.Athigherconcentrations
(0.75–1mg/mL), the extract was toxic to cells because itAdvances in Pharmacological Sciences 5
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Figure 4: Eﬀect of a 24-hour exposure of an aqueous extract of
T. polium on reduced glutathione (GSH) levels in HepG2 cultured
cells. Data are presented as mean ± standard deviation. Sample size
(n) = 8. ∗p<0.01 represents the signiﬁcance of the diﬀerence from
the control.
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Figure 5: Eﬀect of a 24-hour exposure of an aqueous extract of T.
polium on glutathione peroxidase activity in HepG2 cultured cells.
Dataarepresentedasmean ±standarddeviation.Samplesize(n) =
10.
inhibited mitochondrial respiration and increased cellu-
lar LDH eﬄux. At concentrations of 0.375mg/mL and
0.5mg/mL, the extract signiﬁcantly increased the intra-
cellular levels of total and reduced glutathione and had
no eﬀect on intracellular amounts of oxidized glutathione.
Since the extract increased the intracellular levels of reduced
glutathione without aﬀecting oxidized glutathione levels, the
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Figure 6: Eﬀect of a 24-hour exposure of an aqueous extract of T.
polium on glutathione reductase activity in HepG2 cultured cells.
Dataarepresentedasmean ±standarddeviation.Samplesize(n) =
10.
GSH/GSSG ratio increased. At the same time, we found that
the extract had no eﬀect on the activities of GPx and GR.
We found that the maximal nontoxic concentration
of the extract of T. polium was between 0.25mg/mL and
0.5mg/mL. Therefore, we then examined the eﬀect of
the extract over this concentration range on intracellular
glutathione homeostasis. We observed that an aqueous
extracts of T. polium at the concentrations of 0.375mg/mL
and 0.5mg/mL increased the intracellular total and reduced
glutathione levels without aﬀecting the intracellular levels
of oxidized glutathione. Accordingly, we presumed that the
extract was capable of increasing the activities of GPx and
GR, which resulted in enhanced intracellular glutathione
cycling. However, we did not see such an eﬀect on the
activities of the two enzymes. It is well documented that
the end product of glutathione biosynthesis is reduced
glutathione [16, 17]. In view of our ﬁndings that the extract
had no eﬀect on the activities of GPx and GR reductase,
we suggest that T. polium enhances intracellular glutathione
levels by promoting the glutathione biosynthetic pathway.
Further experiments on the eﬀect of the extract on the
activity of glutathione synthetase are needed to verify this
suggestion.
The possible antioxidant mechanism of action of the
extract includes its ability to scavenge reactive oxygen
species or/and enhance endogenous antioxidants levels. In
present study we found that T. polium has an ability to
augment the levels of an important intracellular antioxidant.
Kadifkova-Panovka and colleagues [18] reported that rats
that the plasma GSH levels of rats that were pretreated
with a T. polium extract before inducing cirrhosis with
carbon tetrachloride were partially depleted when compared
to the plasma levels in untreated CCl4-induced cirrhotic
rats. Their ﬁnding suggests that T. polium extract has a
possible hepatoprotective eﬀect. Accordingly, this might be6 Advances in Pharmacological Sciences
the underlying reason why this plant is used to treat liver
disease in traditional Arab medicine.
Although we did not try to identify the antioxidant
bioconstituents of T. polium in this study, Rizk et al. reported
that the aerial parts of the plant are rich with ﬂavonoids
[19]. Flavonoids exhibit many biological activities, such as
antitumoral,antiischemic,antiallergic,anti-hepatotoxic,and
antiinﬂammatory activities, and many of these activities are
attributed to their antioxidant potential [20–22]. Flavonoids
and other phenolic compounds have been reported as
scavengers of reactive oxygen species and inhibitors of
lipid peroxidation [23]. There are some reports of the
eﬀects of some ﬂavonoids on glutathione. Zhang demon-
strated that simultaneous supplementation with quercetin
restored GSH content after oxidative damage in cultured
spermatogonial cells [24]. Other researchers demonstrated
that ﬂavonoids could stimulate the transcription of the
gene(s) that are responsible for intracellular GSH synthesis
[25, 26]. Flavonoids are the not only constitutes of T.
polium. T. polium also contains various diterpenoids [27]
and furanoneoclerodane diterpenoids which are known
hepatotoxins [28–30]. Although diterpenoids can be toxic
to cells, we could not found any evidence of such an
activity at low concentrations of the T. polium extract
that was used in this study. Nevertheless, we found that
T. polium is toxic to cells at higher concentrations, and
such compounds could be the bioactive constituents that
are responsible for the observed cytotoxicity at the higher
concentrations. Furthermore, it should not be overlooked
that we investigated the eﬀects of the extract in a cell
culture system in which the toxic diterpenoid concentration
would increase as the extract concentration increases. We
proposethisasthereasonfortheinhibitionofmitochondrial
respiration and increase of cellular LDH eﬄux at the higher
concentrations of aqueous extract of T. polium. Therefore,
further investigations are needed in order to clarify the
mechanism of the hepatoprotectant action of ﬂavonoids and
hepatotoxic action of dipertenoids in the various types of T.
polium extracts whose ﬂavonoid and dipertenoid levels may
vary according to the location and season of plant collection,
and the preparation and type of extract.
Our results also provide some insight into the contro-
versy on the safety and hepatoprotective and hepatotoxic
potential of T. polium extracts because they highlight the
delicate balance between the beneﬁcial and toxic eﬀects
of a T. polium extract on glutathione homeostasis and
cellular integrity. There are now many reports on T. polium-
induced hepatotoxicity with sometimes severe and fatal
c o m p l i c a t i o n si nh u m a n s[ 30–37]. This hepatotoxicity has
been conﬁrmed in laboratory animals [27, 28, 38, 39]
a n dc u l t u r e dh e p a t o c y t e s[ 4, 5]. In this study, we demon-
strated that cellular integrity is unaﬀected at low extract
concentrations, and continues to be unaﬀected despite
nonsigniﬁcant increases in intracellular glutathione levels
as extract concentration increases. Further modest increases
in extract concentration cause an additional increase in
intracellular glutathione levels and appearance of impaired
cellular integrity (reduced mitochondrial respiration and
increased LDH leakage). In other words, the concentrations
at which the extract increases intracellular glutathione levels
coincide with those that can impair cellular integrity.
In conclusion, our data indicates that, at low concen-
trations, an aqueous extract of T. polium is not toxic and
the mechanism of the hepatoprotective action of aqueous
extract may be, in part, due to enhancement of intracellular
glutathione levels. The mechanism of this increase is not due
to the extract accelerating intracellular glutathione recycling,
but could be due to an eﬀect on glutathione biosynthesis.
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